The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ENGAGE-1: A first in human study of the OX40 agonist GSK3174998 alone and in combination with pembrolizumab in patients with advanced solid tumors.
 
Jeffrey R. Infante
Consulting or Advisory Role - GlaxoSmithKline (Inst)
Research Funding - GlaxoSmithKline (Inst)
 
Christoph M Ahlers
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline
 
F. Stephen Hodi
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche
 
Sophie Postel-Vinay
No Relationships to Disclose
 
Jan H. M. Schellens
No Relationships to Disclose
 
John Heymach
Honoraria - AstraZeneca; Boehringer Ingelheim; Exelixis; Genentech/Roche; GlaxoSmithKline; Lilly; Novartis; Synta
Research Funding - AstraZeneca (Inst); Bayer (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Novartis
 
Karen A. Autio
Research Funding - ARMO BioSciences (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
 
Mary S. Barnette
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Herbert Struemper
Employment - GlaxoSmithKline; Parexel
Stock and Other Ownership Interests - GlaxoSmithKline
 
Maura Watmuff
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Elaine Marie Paul
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
David Ross Kaufman
Employment - Merck
Stock and Other Ownership Interests - Merck
Patents, Royalties, Other Intellectual Property - Merck
Travel, Accommodations, Expenses - Merck
 
Jeffrey S. Weber
Stock and Other Ownership Interests - Altor BioScience; Celldex; Merck
Honoraria - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Consulting or Advisory Role - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
 
Axel Hoos
Employment - GlaxoSmithKline
Leadership - Imugene
Stock and Other Ownership Interests - GlaxoSmithKline; Imugene